Safety of Fezolinetant for Vasomotor Symptoms Associated With MenopauseObstetrics and GynecologyMarch 9, 202310.1097/aog.0000000000005114Cited by 110SaveCiteExport RISWatch citationsRelated PapersNo related papers foundPowered by citation graph analysis